Preexposure Prophylaxis Monitoring in New York City: A Public Health Approach.

Am J Public Health

Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene.

Published: November 2018

The scale-up of preexposure prophylaxis (PrEP) represents a paradigm shift in HIV prevention that poses unique challenges for public health programs. Monitoring of PrEP implementation at the population level is a national priority, with particular significance in New York City (NYC) given the substantial HIV burden and the prominence of PrEP in state and local Ending the Epidemic program plans. We highlight the importance of local monitoring and evaluation of PrEP implementation outcomes and describe the experience at the NYC Health Department, which includes engaging communities, triangulating a variety of data sources regarding PrEP implementation, and leveraging those data to help guide programming. In NYC, we used data from national surveillance systems and incorporated PrEP-related indicators into existing local data collection systems to help illustrate gaps in PrEP awareness and use. Ultimately, ensuring that PrEP achieves the desired impact at the population level depends on identifying disparities through appropriate and accurate measurement, and addressing them through evidence-based programs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215383PMC
http://dx.doi.org/10.2105/AJPH.2018.304729DOI Listing

Publication Analysis

Top Keywords

prep implementation
12
preexposure prophylaxis
8
york city
8
public health
8
population level
8
prep
7
prophylaxis monitoring
4
monitoring york
4
city public
4
health approach
4

Similar Publications

Background: Women involved in the criminal legal system have elevated rates of opioid use disorder, which is treatable, and HIV, which is preventable with pre-exposure prophylaxis (PrEP). There are significant social and structural barriers to integrated delivery of PrEP and medications for opioid use disorder (MOUD), limiting women's ability to access these life-saving interventions. In a two parallel-arm randomized controlled trial, we are assessing an innovative eHealth delivery model that integrates PrEP with MOUD and is tailored to meet the specific needs of women involved in the criminal legal system.

View Article and Find Full Text PDF

Background: Sexual and gender minority (SGM) adolescents in the United States are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) is a highly effective biomedical HIV prevention method, but its awareness and uptake among SGM adolescents are low. There are no adolescent-centered PrEP social marketing campaigns in the United States that have the potential to increase awareness and interest in PrEP.

View Article and Find Full Text PDF

Objective: We aimed to identify preferences for PrEP care among diverse gay, bisexual, and other men who have sex with men (BLGBM) in the US with discrete choice experiment (DCE).

Design: We conducted two DCEs to elicit care delivery preferences for Starting and Continuing PrEP among 16-49 year-old HIV negative GBM not using PrEP from across the United States. DCEs assessed preferences for care options including location, formulation (pills, injectable), lab testing, and costs.

View Article and Find Full Text PDF

HIV prevention among adolescents travestis and transgender women in three Brazilian capitals, 2019-2023.

Epidemiol Serv Saude

January 2025

Universidade Federal da Bahia, Instituto de Saúde Coletiva, Salvador, BA, Brazil.

Objective: To describe HIV prevention strategies and gender-based discrimination among adolescent travestis and transgender women.

Methods: This was a cross-sectional study involving 148 adolescent travestis and transgender women aged 15 to 19 years in Salvador, Bahia state, São Paulo, São Paulo state, and Belo Horizonte, Minas Gerais state, conducted between February 2019 and March 2023. Fisher's exact test was performed to assess differences between prevention strategies and gender-based discrimination within healthcare services.

View Article and Find Full Text PDF

Background: HIV pre-exposure prophylaxis (PrEP) remains particularly underutilized among homeless-experienced people who use drugs (PWUD).

Setting: Boston Health Care for the Homeless Program, a Federally Qualified Health Center serving homeless-experienced individuals in Boston, Massachusetts.

Methods: To identify determinants of PrEP prescription initiation and continuation, we analyzed electronic medical records and pharmacy data between April 2018-March 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!